Fabia Tetteroo-Bueno Joins Lapsi Health to Spearhead Latin America Expansion

Leadership Transition in Lapsi Health

In a significant development for the healthcare technology sector, Lapsi Health, a pioneering Dutch company specializing in clinical AI, has appointed Fabia Tetteroo-Bueno to its Board of Directors. Known for her role as the former Senior Vice President and General Manager of Philips Latin America, Tetteroo-Bueno is expected to be instrumental in steering Lapsi's initiatives as they broaden their reach across Latin America, particularly through their innovative platform, Keikku.

A New Face at the Helm

Tetteroo-Bueno brings over two decades of extensive global healthcare experience to her new role. Under her leadership at Philips Latin America, she has successfully navigated the complexities of the healthcare landscape, especially during the unprecedented challenges posed by the COVID-19 pandemic. Her mission has consistently been focused on expanding access to quality healthcare services. As the first woman to take on the leadership role at Philips in Latin America, she has proven her capabilities and commitment to enhancing healthcare technologies.

Plans for Expansion

In her new capacity at Lapsi Health, Tetteroo-Bueno is poised to drive the strategy and cultivate partnerships essential for Keikku’s expansion in the region. Keikku’s growth trajectory has already begun, with notable advancements like the establishment of an office in Santiago and strategic collaborations with the SMC and SOMEIC.

“Fabia has spent her career demonstrating that healthcare technology is only meaningful if it is accessible to those who need it,” remarked Jhonatan Bringas Dimitriades, the CEO and co-founder of Lapsi Health. He expressed optimism about Tetteroo-Bueno’s leadership as the company deepens its footprint across Latin America.

Commitment to Quality and Safety

“I believe that verified clinical technology should be available in Latin America, not just in the U.S. or Europe,” Tetteroo-Bueno stated. Her push for high standards within healthcare technology is reflected in Keikku’s CE certification, which assures the safety and quality of its services. Tetteroo-Bueno aims for healthcare professionals throughout the region to access the same rigorous technology used in developed markets.

Seizing the Moment

Currently, Latin America represents one of the fastest-growing markets for Keikku. The platform offers three key solutions tailored for Spanish and Portuguese-speaking healthcare providers: Keikku Scribe, which converts patient dialogues into structured clinical notes in real-time; Keikku Reference, an AI-driven clinical decision support tool; and Keikku Telemedicina, designed for virtual consultations.

With these innovations, Keikku enables clinicians to concentrate more on patient care by alleviating the burden of documentation and administrative tasks. Tetteroo-Bueno underscored her commitment to Lapsi Health’s mission: “I have a strong belief in this technology and the future roadmap ahead, and I am excited to support Lapsi in its efforts to introduce this to Latin America.”

About Lapsi Health

Founded in 2022 in Amsterdam, Lapsi Health is committed to setting benchmarks in healthcare AI through its platform, Keikku, which integrates an FDA-cleared ambient microphone system with a suite of AI tools focusing on clinical documentation, reference, and auscultation. Lapsi is ISO 13485 certified, ensuring compliance with internationally recognized quality standards. Keikku is already being utilized in leading medical institutions across Europe and the USA, paving the way for a promising future.

In summary, Fabia Tetteroo-Bueno's appointment as a Board member in Lapsi Health is not just a pivotal moment for the company but also a significant step forward for healthcare technology accessibility in Latin America. With her vast experience and strategic vision, the pathway for Lapsi Health's expansion is set to be transformative for the region.